IL50892A - 2-(5-tetrazolyl-or 5-tetrazolylalkyl)imidazoles and benzimidazoles, process for their preparation and pharmaceutical compositions containing them - Google Patents

2-(5-tetrazolyl-or 5-tetrazolylalkyl)imidazoles and benzimidazoles, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL50892A
IL50892A IL50892A IL5089276A IL50892A IL 50892 A IL50892 A IL 50892A IL 50892 A IL50892 A IL 50892A IL 5089276 A IL5089276 A IL 5089276A IL 50892 A IL50892 A IL 50892A
Authority
IL
Israel
Prior art keywords
tetrazolylalkyl
benzimidazoles
tetrazolyl
imidazoles
preparation
Prior art date
Application number
IL50892A
Other languages
English (en)
Other versions
IL50892A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL50892A0 publication Critical patent/IL50892A0/xx
Publication of IL50892A publication Critical patent/IL50892A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL50892A 1975-11-13 1976-11-11 2-(5-tetrazolyl-or 5-tetrazolylalkyl)imidazoles and benzimidazoles, process for their preparation and pharmaceutical compositions containing them IL50892A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IL50892A0 IL50892A0 (en) 1977-01-31
IL50892A true IL50892A (en) 1981-02-27

Family

ID=5961645

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50892A IL50892A (en) 1975-11-13 1976-11-11 2-(5-tetrazolyl-or 5-tetrazolylalkyl)imidazoles and benzimidazoles, process for their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US4152440A (fr)
JP (3) JPS5262278A (fr)
AT (1) AT357155B (fr)
AU (1) AU504009B2 (fr)
BE (1) BE848280A (fr)
CA (1) CA1097350A (fr)
DE (1) DE2550959C3 (fr)
DK (1) DK511376A (fr)
ES (1) ES453276A1 (fr)
FI (1) FI763215A (fr)
FR (1) FR2363328A1 (fr)
GB (1) GB1545939A (fr)
GR (1) GR70648B (fr)
HU (1) HU173879B (fr)
IE (1) IE44184B1 (fr)
IL (1) IL50892A (fr)
LU (1) LU76188A1 (fr)
NL (1) NL7612610A (fr)
NO (1) NO763876L (fr)
SE (1) SE7612685L (fr)
ZA (1) ZA766715B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
KR101170925B1 (ko) * 2004-06-18 2012-08-07 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 암 치료용 키네신 방추 단백질 (ksp) 억제제로서의n-(1-(1-벤질-4-페닐-1h-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물
MX2009007260A (es) * 2007-01-05 2009-07-10 Novartis Ag Derivados de imidazol como inhibidores de proteina de huso de cinesina (eg-5).
TW200916098A (en) * 2007-06-14 2009-04-16 Teijin Pharma Ltd Agent for lowering uric acid level
CN102186833A (zh) * 2008-08-18 2011-09-14 耶鲁大学 Mif调节剂
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2508511A1 (fr) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibiteurs de la réplication virale, leur procédé de préparation et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (fr) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (fr) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AT357155B (de) 1980-06-25
DE2550959C3 (de) 1980-12-04
FR2363328A1 (fr) 1978-03-31
GR70648B (fr) 1982-12-03
NL7612610A (nl) 1977-05-17
IE44184B1 (en) 1981-09-09
DE2550959A1 (de) 1977-05-26
JPS5531155B2 (fr) 1980-08-15
SE7612685L (sv) 1977-05-14
FI763215A (fr) 1977-05-14
JPS54163578A (en) 1979-12-26
JPS5262278A (en) 1977-05-23
DK511376A (da) 1977-05-14
NO763876L (fr) 1977-05-16
BE848280A (fr) 1977-05-12
LU76188A1 (fr) 1977-06-06
ES453276A1 (es) 1978-02-01
US4152440A (en) 1979-05-01
IE44184L (en) 1977-05-13
FR2363328B1 (fr) 1979-08-31
GB1545939A (en) 1979-05-16
ATA844476A (de) 1979-11-15
ZA766715B (en) 1977-10-26
AU1952576A (en) 1978-05-18
HU173879B (hu) 1979-09-28
JPS5547677A (en) 1980-04-04
DE2550959B2 (de) 1980-04-10
AU504009B2 (en) 1979-09-27
CA1097350A (fr) 1981-03-10
IL50892A0 (en) 1977-01-31

Similar Documents

Publication Publication Date Title
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
GB1518444A (en) N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them
ZA794472B (en) Pyridazinone-substituted benzimidazoles,processes for their preparation,and pharmaceutical compositions thereof
ZA752871B (en) New heterocyclic compounds, process for preparing them and pharmaceutical compositions containing the same
IL47394A0 (en) Heterocyclic guanidine derivatives,process for their preparation and pharmaceutical compositions containing them
IL49411A0 (en) Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL49406A0 (en) Novel imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL55109A (en) 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them
IL51040A (en) 2-heteroarylmethylthioethylamino-5-heteroarylalkylpyrimidin-4-one derivatives,process for their preparation und pharmaceutical compositions containing them
DE2963573D1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
EP0001280A3 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
DE2964209D1 (en) Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them
IL50736A0 (en) Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH14563A (en) Derivatives of substituted n-alkyl imidazoles,their pharmaceutical composition and method of use
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
IL50230A (en) 4,5-diphenyl-2-(substituted thio-sulfonyl)imidazole derivatives their preparation and pharmaceutical compositions containing them
IL50892A (en) 2-(5-tetrazolyl-or 5-tetrazolylalkyl)imidazoles and benzimidazoles, process for their preparation and pharmaceutical compositions containing them
DE2965259D1 (en) Heterocycle substituted (3-loweralkylamino-2-ro-propoxy)pyridines, process for preparing the same,and pharmaceutical composition containing the same
IL52148A (en) Substituted 1-phenoxy-2-hydroxy-3-aminopropanes,process for preparing same and pharmaceutical compositions containing them
EP0000500A3 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
JPS5218831A (en) Pharmaceutical composition containing antiiimflammation substance and imidazole or benzimidazole
IL49546A0 (en) New imidazole derivatives,their production and pharmaceutical compositions containing them
ZA786369B (en) New derivatives of 5h-benzocyclohepten-7-amine and their salts,process for preparing them and the pharmaceutical compositions containing them
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them
IL54810A0 (en) 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing same, process for preparing such compositions and their use as antidepressive medicaments